The question of radiology obsolescence is really a question about the future of white-collar work itself—any profession rooted in human knowledge, analysis, or judgment. If that’s the concern, maybe the safest advice isn’t “don’t be a radiologist,” but “enter a trade or own an experiential business such as a resort.” Though even those may not be safe forever. Perhaps the best hedge is owning power plants. The takeaway is this: if you’re young and worried about radiology, you should probably be worried about nearly every other career resting on human judgement too. Radiology may be in the spotlight, but if AI replaces us, we certainly won’t be the only ones.
For both current and future radiologists, finding the right job is a major life decision—one that will shape your career, finances, and personal happiness for years to come. Yet many trainees enter the job search without the tools they need to navigate it effectively. This guide offers practical strategies to help you secure a radiology position that aligns with your goals, values, and lifestyle.
As we stand on what many call the precipice of generative AI, I keep asking myself one simple question: how is it possible, with all this AI capability around us, that some of the most basic tools radiologists have wanted for years still don’t exist or are not available for widespread clinical use?
If done well—with transparent grading, standardized cases, and accessible prep materials—the oral boards could become a meaningful assessment of clinical reasoning, and have potential to improve the knowledge base of new radiologists.
But if poorly implemented, this could add significant stress, widen gaps between programs, and further burden early-career radiologists, who are frankly already struggling to get by with volume expectations their older radiology peers didn’t have to face straight out of training.
ChatGPT’s take surprised me — radiologists aren’t going anywhere during my career. Its timeline for AI disruption is both fascinating and reassuring for current radiologists… if it turns out to be true. I’m also relieved that my podcast is predicted to be safe from AI, at least for now. No matter what, I’ll keep doing what human radiologists do best — reading images, performing procedures, and consulting ChatGPT about the deep existential questions of our future.
Radioligand therapy for breast cancer isn’t science fiction—it’s science that’s finally starting to catch up with the need. The potential is enormous. The stakes are high. And the urgency is real…If we do this right, we’ll not only give patients more time—but more quality time. And that, after all, is the point.
Whether you’re a trainee just figuring out how to navigate PACS without rage-quitting, or an attending who’s been using the same mouse settings since the Bush administration, this book delivers practical, actionable tips to upgrade your efficiency—and maybe even your sanity.,,It’s a no-brainer investment in your efficiency.
If you listen to the media, AI is already revolutionizing radiology and putting me out of a job. Let me assure you: hospitals would love for that to be true. Radiologists are in short supply. But it’s not true. Not even close.
AI has tremendous potential. It could help general radiologists, serve as a second reader, and maybe someday even write a clean, coherent report or fix our bloated EMRs. But today? It’s not the revolution we’re being sold.
This meeting felt like a real turning point — and one that will ultimately lead to better care for millions of women.
Radiologists, AI developers, and the media alike must adopt an objective, evidence-based approach to AI. Hype can undermine patient care by fostering unrealistic expectations and encouraging the premature or risky use of AI technologies. While RSNA 2024 showcased exciting advances, it also underscored how far we are from AI truly revolutionizing radiology.
As one lecture concluded: “AI is here—embrace it, validate it, advance it.” I would add: “and approach it with realism and a healthy dose of skepticism.”
With billions of dollars now directed toward its development, radioligand therapy has the potential to transform cancer treatment. The excitement is driving cancer centers nationwide to expand theranostic trials which pair RLT with novel radiopharmaceutical PET or SPECT imaging. However, one critical challenge looms: a shortage of nuclear medicine and radiology physician experts, technologists, and nursing staff capable of delivering this therapy at scale.
This expanded “usually appropriate” rating from the ACR could make MRI screenings accessible to a greater number of individuals with dense breast tissue, likely with insurance support. Typically, insurers cover procedures rated “usually appropriate” by the ACR, but this will test their willingness to cover the high-cost breast MRI exams.
This meeting focuses just as much on what we don’t know, as what we do know. Thus, this is a fantastic opportunity to not only obtain current knowledge, but also establish a framework to guide future research. Furthermore, this allows us to face, with greater conviction, the dilemma that is ILC.
“…Outlive offers a thought-provoking reexamination of health priorities, advocating for a paradigm shift towards proactive health management. While some recommendations may seem lofty, the underlying principles hold promise for improving individual and societal well-being if embraced and implemented effectively.”
Ensure your reports are accessible to a wide audience by avoiding obscure abbreviations and phrases. Consider the diverse range of medical professionals who may read your reports and strive for clarity and comprehensibility. Simplify complex terms or provide explanations when necessary to facilitate understanding.
Swift action is needed to detect ILC early, utilizing available technologies and conducting ILC-specific research.
“Progress demands adaptation. Pending a perfect knowledge of the body and mind some proportion of commonly accepted medical knowledge will be untrue. Therefore, question absolutes in medicine. Keep an open mind and a broad perspective. Do not assume that everything you were taught in medical school must be true.”
“Short of a silver bullet cure for metastatic breast cancer, can we achieve close to 100% reduction in breast cancer mortality using current screening technologies? A careful re-assessment and re-implementation of current screening approaches may get us much closer. If this topic interests you, read on.”